| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |